Wellona Pharma is a reliable manufacturer and exporter of Cefpodoxime & Potassium Clavulanate Tablets, supplying advanced combination antibiotics to international pharmaceutical markets. This formulation combines the broad-spectrum activity of Cefpodoxime with the beta-lactamase inhibiting action of Clavulanic acid, enhancing effectiveness against resistant bacterial strains.
Cefpodoxime belongs to the beta-lactam antibiotic class and works by inhibiting bacterial cell wall synthesis. When combined with Potassium Clavulanate, the formulation helps overcome bacterial resistance mechanisms, ensuring improved clinical outcomes in moderate to severe infections.
Combination antibiotic therapy is widely used to improve treatment success in infections caused by beta-lactamase producing organisms. Cefpodoxime & Potassium Clavulanate Tablets are commonly prescribed for:
The synergistic action of this combination plays an important role in addressing the growing concern of antibiotic resistance in clinical practice.
As an experienced Cefpodoxime & Potassium Clavulanate Tablets exporter, Wellona Pharma offers:
Our antibiotic formulations are developed to meet international pharmacopoeial and regulatory standards, ensuring safety, efficacy, and long-term stability.
Explore detailed product specifications and packaging options for Cefpodoxime & Potassium Clavulanate Tablets.
You may also review other quality formulations from our product portfolio, such as Clopidogrel Tablets, manufactured under stringent quality standards.
If you are looking for a dependable partner for combination antibiotic manufacturing and export, Wellona Pharma offers expertise, scalability, and consistent quality assurance.
For bulk supply, export inquiries, or distribution partnerships, reach out through our contact page.